Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Carbapenem

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ph3 PIVOT-PO Data Show Tebipenem HBr as First Oral Carbapenem
    Ph3 PIVOT-PO Data Show Tebipenem HBr as First Oral Carbapenem

    21 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/21/3169930/0/en/PIVOT-PO-Phase-3-Data-Show-Tebipenem-HBr-s-Potential-as-the-First-Oral-Carbapenem-Antibiotic-for-Patients-with-Complicated-Urinary-Tract-Infections-cUTIs.html

    GLOBENEWSWIRE
    21 Oct 2025
    Share Share
    Spero Pharma Presents Tebipenem Hbr Data At IDweek
    Spero Pharma Presents Tebipenem Hbr Data At IDweek

    14 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/14/3166146/0/en/Spero-Therapeutics-Announces-Presentations-on-Tebipenem-Hbr-at-IDWeek.html

    GLOBENEWSWIRE
    14 Oct 2025
    Share Share
    iNtRON Files US Patent for 3 New Endolysin Drug Candidates
    iNtRON Files US Patent for 3 New Endolysin Drug Candidates

    02 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/intron-files-us-patent-for-three-novel-endolysin-based-drug-candidates-targeting-gram-negative-bacteria-302496380.html

    PR NEWSWIRE
    02 Jul 2025
    Share Share
    GSK, Spero stop UTI drug trial after early success
    GSK, Spero stop UTI drug trial after early success

    29 May 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/gsk-spero-stop-urinary-tract-infection-drug-trial-due-early-success-2025-05-28/

    REUTERS
    29 May 2025
    Share Share
    Venus Remedies Gets Ukrainian GMP Renewal Certification
    Venus Remedies Gets Ukrainian GMP Renewal Certification

    24 May 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/venus-remedies-gets-ukrainian-gmp-renewal-certification/articleshow/121376057.cms

    ECONOMICTIMES
    24 May 2025
    Share Share
    Venus Remedies secures Ukrainian GMP renewal
    Venus Remedies secures Ukrainian GMP renewal

    23 May 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/venus-remedies-secures-ukrainian-gmp-renewal-17192

    INDPHARMAPOST
    23 May 2025
    Share Share